{"AllianceGenome": "11744", "HGNC": "11744", "MIM": "601602", "_id": "7022", "_version": 2, "accession": {"genomic": ["AB041717.3", "AF544986.1", "AJ315934.1", "AL121920.21", "CH471077.2", "CP068258.2", "KT584586.1", "NC_000020.11", "NC_060944.1"], "protein": ["AAC51305.1", "AAH35664.2", "AAH51829.2", "AAN37906.1", "BAC11805.1", "BAG36933.1", "BAG63065.1", "CAA64989.1", "CAC86997.1", "EAW75532.1", "NP_003213.1", "Q92754.1"], "rna": ["AK301572.1", "AK314272.1", "BC035664.1", "BC051829.1", "NM_003222.4", "U85658.1", "X95693.1"], "translation": [{"protein": "BAG63065.1", "rna": "AK301572.1"}, {"protein": "BAG36933.1", "rna": "AK314272.1"}, {"protein": "CAA64989.1", "rna": "X95693.1"}, {"protein": "AAC51305.1", "rna": "U85658.1"}, {"protein": "AAH35664.2", "rna": "BC035664.1"}, {"protein": "NP_003213.1", "rna": "NM_003222.4"}, {"protein": "AAH51829.2", "rna": "BC051829.1"}]}, "alias": ["AP2-GAMMA", "ERF1", "TFAP2G", "hAP-2g"], "ensembl": {"gene": "ENSG00000087510", "protein": ["ENSP00000201031", "ENSP00000390857"], "transcript": ["ENST00000201031", "ENST00000416606"], "translation": [{"protein": "ENSP00000201031", "rna": "ENST00000201031"}, {"protein": "ENSP00000390857", "rna": "ENST00000416606"}], "type_of_gene": "protein_coding"}, "entrezgene": "7022", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 13.0385227285, "exp_mis": 183.191480985, "exp_syn": 106.255721216, "lof_z": 3.30254485098676, "mis_z": 3.47616593796416, "mu_lof": 9.33543317457e-07, "mu_mis": 1.71769115917e-05, "mu_syn": 9.95135520438e-06, "n_lof": 1.0, "n_mis": 87.0, "n_syn": 70.0, "p_li": 0.939950974403548, "p_null": 5.01051167995404e-05, "p_rec": 0.0599989204796529, "syn_z": 2.18046732457518}, "bp": 1353, "cds_end": 55213069, "cds_start": 55204600, "n_exons": 7, "nonpsych": {"exp_lof": 11.6598658709, "exp_mis": 165.664717357, "exp_syn": 96.0304284432, "lof_z": 3.06589255705082, "mis_z": 3.51372854133182, "mu_lof": 9.33543317457e-07, "mu_mis": 1.71769115917e-05, "mu_syn": 9.95135520438e-06, "n_lof": 1.0, "n_mis": 76.0, "n_syn": 62.0, "p_li": 0.914496633015469, "p_null": 0.000149984536718467, "p_rec": 0.0853533824478122, "syn_z": 2.18638443711486}, "nontcga": {"exp_lof": 11.981672653, "exp_mis": 168.522406066, "exp_syn": 97.7415019021, "lof_z": 3.12961520919147, "mis_z": 3.43568035355222, "mu_lof": 9.33543317457e-07, "mu_mis": 1.71769115917e-05, "mu_syn": 9.95135520438e-06, "n_lof": 1.0, "n_mis": 79.0, "n_syn": 64.0, "p_li": 0.916491967815247, "p_null": 0.000115625309070665, "p_rec": 0.0833924068756819, "syn_z": 2.16096251653596}, "transcript": "ENST00000201031.2"}, "exons": [{"cdsend": 56638013, "cdsstart": 56629544, "chr": "20", "position": [[56629305, 56629592], [56631204, 56631690], [56631804, 56631856], [56633352, 56633569], [56634149, 56634268], [56636609, 56636754], [56637727, 56639282]], "strand": 1, "transcript": "NM_003222", "txend": 56639282, "txstart": 56629305}], "exons_hg19": [{"cdsend": 55213069, "cdsstart": 55204600, "chr": "20", "position": [[55204361, 55204648], [55206260, 55206746], [55206860, 55206912], [55208408, 55208625], [55209205, 55209324], [55211665, 55211810], [55212783, 55214338]], "strand": 1, "transcript": "NM_003222", "txend": 55214338, "txstart": 55204361}], "generif": [{"pubmed": 11773066, "text": "AP-2 gamma and Dlx 3, together with an additional transcription factor(s) that are conserved between humans and mice, are required for trophoblast-specific expression of 3 beta-HSD VI."}, {"pubmed": 11859873, "text": "AP-2gamma is important in regulation of ErbB-3 expression in human mammary epithelial and lung fibroblast cells"}, {"pubmed": 12228234, "text": "AP2 regulates human reduced folate carrier gene expression"}, {"pubmed": 12801994, "text": "we have identified a potential trophoblast cell-specific regulatory element located 6 kb upstream of the murine AP-2gamma gene transcription start site, and that Sp1 and Sp3 bind to cis-regulatory elements located in the promoter proximal region"}, {"pubmed": 12833450, "text": "likely prognostic indicator for patients with breast tumors"}, {"pubmed": 14565844, "text": "AP-2gamma expression in breast cancer cells is induced by oestrogens through binding of the oestrogen receptor to a response element within the 5'-untranslated region."}, {"pubmed": 15569994, "text": "Expression of MMP-2 and MMP-9 in breast cancer seems to be partly related to expression of AP-2 and HER2"}, {"pubmed": 15700319, "text": "Abundant expression of AP-2gamma is associated with intratubular germ cell neoplasias"}, {"pubmed": 16636674, "text": "Expression microarray results in human breast carcinoma cells with forced p53 expression revealed AP-2gamma as a putative transcriptional target of p53."}, {"pubmed": 16867219, "text": "expression of either AP-2gamma or AP-2alpha induces p21 and inhibits breast carcinoma cell growth"}, {"pubmed": 17875680, "text": "TFAP2C is the key regulator of hormone responsiveness in breast carcinoma cells through the control of multiple pathways of estrogen signaling. TFAP2C regulates the expression of ERalpha directly by binding to the ERalpha promoter."}, {"pubmed": 17947476, "text": "Wwox and Ap2gamma emerge are tumor biomarkers that may be superior to PR and Her2 in predicting tamoxifen response"}, {"pubmed": 18042070, "text": "AP2 transcription factors may play decisive pacemaker roles in initiating and coordinating budding and branching processes during formation of the fetal breast anlage"}, {"pubmed": 18443366, "text": "Down-modulation of AP-2gamma expression in tumor cells by RNA interference led to enhanced tumor growth and reduced chemotherapy-induced cell death, as well as migration and invasion."}, {"pubmed": 19130459, "text": "Reduced expression levels of nuclear AP2gamma is associated with the pathogenesis of basal-like differentiation in breast cancer."}, {"pubmed": 19443578, "text": "The present data suggest that AP-2 may suppress trophoblast migration and invasion, thus leading to a shallow placentation in preeclampsia."}, {"pubmed": 19458056, "text": "Data show that the combination of increasing chromatin accessibility and inducing TFAP2C provides a more robust activation of the ERalpha gene in ERalpha-negative breast cancer cells."}, {"pubmed": 19671168, "text": "ErbB2, CDH2, HPSE and IGSF11 are identified as AP-2gamma target genes in breast cancer cells."}, {"pubmed": 19798054, "text": "AP-2gamma promotes proliferation in breast tumour cells by direct repression of the CDKN1A gene."}, {"pubmed": 20629094, "text": "Overexpression of TFAP2C is associated with hormone responsive breast carcinoma."}, {"pubmed": 21468029, "text": "miR-214 is highly expressed in human melanomas and the data suggest a critical role for this miRNA in disease progression and the establishment of distant metastases through suppression of TFAP2C."}, {"pubmed": 21572391, "text": "AP-2gamma is a novel collaborative factor in ERalpha-mediated transcription."}, {"pubmed": 22371483, "text": "demonstrated that while TFAP2C and Myc can downregulate the CDKN1A promoter independently, KDM5B acts as a corepressor dependent on the other two proteins"}, {"pubmed": 22560121, "text": "results substantiate a role for Tcfap2c/ TFAP2C in supporting proliferation and repressing differentiation in cellular compartments representing immature/ progenitor cells.[review]"}, {"pubmed": 22702469, "text": "We demonstrated that TFAP-2gamma is one of the transcription factors involved in the HuPAR-2 expression in human villous trophoblast cells."}, {"pubmed": 22878616, "text": "TFAP2C regulates expression of the RET proto-oncogene through five AP-2 regulatory sites in the RET promoter."}, {"pubmed": 22964634, "text": "Results demonstrate that TFAP2C regulates the expression of GPX1, which influences the redox state and sensitivity to oxidative stress induced by peroxides."}, {"pubmed": 23036739, "text": "ESDN and AP-2g expression is lower in thick melanomas, it is associated with unfavourable histo-pathological parameters (increased vascularity, vascular invasion and mitoses) and correlates with a shorter DFS like for AP-2a."}, {"pubmed": 23334330, "text": "TFAP2C amplification and overexpression represents a genetic dependency in ERBB2+ve breast cancer."}, {"pubmed": 24023917, "text": "role for TFAP2C in melanoma via its regulation of ECM1"}, {"pubmed": 24045439, "text": "Knockdown of TFAP2C or RET inhibited activation of ERK and AKT in MCF-7 cells. Knockdown of TFAP2C, which controls ER (estrogen receptor) and RET, had a greater effect on cell growth than either RET or ER alone."}, {"pubmed": 24469049, "text": "TFAP2C has an important role in regulated luminal-specific genes and may be a viable therapeutic target in breast cancer."}, {"pubmed": 24969902, "text": "ShRNA knockdown of AP-2gamma in neuroblastoma cells results in significant inhibit of cell proliferation."}, {"pubmed": 25315380, "text": "In all three groups[preeclamptic placentas , healthy control and smokers] expression rates of AP-2gamma did not differ between primary, secondary and tertiary villi."}, {"pubmed": 26160249, "text": "Higher TFAP2C protein expression correlates with poor overall survival after 10 years of diagnosis in ERalpha-positive breast cancer."}, {"pubmed": 27593936, "text": "TFAP2C might increase oncogenic miR-183 expression and consequently downregulate tumor-suppressive AKAP12 and decrease tumor-suppressive miR-33a expression and subsequently induce CDK6 in NSCLC cells."}, {"pubmed": 27885255, "text": "This study shows that TFAP2C promoted lung tumor progression by upregulation of TGFBR1 and consequent activation of PAK1 signaling."}, {"pubmed": 28610956, "text": "miR-137 is a Slug-induced miRNA that relays the pro-metastatic effects of Slug by targeting TFAP2C in non-small cell lung cancer cells."}, {"pubmed": 29035388, "text": "Study discovered a novel enhancer HER2 gene body enhancer (HGE) in the 3' gene body of HER2. The HGE activates promoters 1 and 2 in trans., and hence the TFAP2C-mediated transcriptional induction of HER2 expression in breast cancer samples."}, {"pubmed": 29439714, "text": "Our findings indicate that TFAP2C may serve as a novel prognostic factor in CRC patients, and a therapeutic target for the treatment of CRC, suggesting that silencing TFAP2C in combination with 5-FU may be an effective therapeutic strategy to improve survival in CRC patients."}, {"pubmed": 29615098, "text": "survival analysis demonstrated that high miR-10a-5p expression levels and low TFAP2C expression levels were both independent adverse prognostic factors in patients with PDAC."}, {"pubmed": 29695788, "text": "TFAP2C establishes and maintains naive human pluripotency and regulates OCT4 expression by mechanisms that are distinct from mouse."}, {"pubmed": 30590035, "text": "deleting the TFAP2C-bound naive enhancer at the OCT4 locus (also called POU5F1) results in impaired OCT4 expression and a negative effect on human primordial germ cells-like cell identity."}, {"pubmed": 30686763, "text": "TFAP2C primes the surface ectoderm chromatin landscape and induces p63 expression and binding sites, thus allowing maturation factor p63 to positively autoregulate its own expression and close a subset of the TFAP2C-initiated surface ectoderm program."}, {"pubmed": 30824562, "text": "Molecular network of transcription factor AP-2 alpha (AP-2alpha) and transcription factor AP-2 gamma (AP-2gamma) and other molecules may clarify the atypical molecular mechanisms occurring during carcinogenesis [Review]."}, {"pubmed": 31542614, "text": "AP2gamma mediated downregulation of LINC00511 suppresses trophoblast invasion by regulating miR-29b-3p/ Cyr61 axis."}, {"pubmed": 31619506, "text": "A TFAP2C Gene Signature Is Predictive of Outcome in HER2-Positive Breast Cancer."}, {"pubmed": 31636386, "text": "TFAP2C regulates carbonic anhydrase XII in human breast cancer."}, {"pubmed": 31659294, "text": "Extracellular matrix anisotropy is determined by TFAP2C-dependent regulation of cell collisions."}, {"pubmed": 32423796, "text": "MiR-29b-3p cooperates with miR-29c-3p to affect the malignant biological behaviors in T-cell acute lymphoblastic leukemia via TFAP2C/GPX1 axis."}, {"pubmed": 32462520, "text": "Comprehensive analysis of the expression and prognosis for TFAP2 in human lung carcinoma."}, {"pubmed": 32857912, "text": "METTL3 potentiates resistance to cisplatin through m(6) A modification of TFAP2C in seminoma."}, {"pubmed": 33213447, "text": "Functional genomics of AP-2alpha and AP-2gamma in cancers: in silico study."}, {"pubmed": 33269540, "text": "Interaction of transcription factor AP-2 gamma with proto-oncogene PELP1 promotes tumorigenesis by enhancing RET signaling."}, {"pubmed": 33608411, "text": "GATA transcription factors, SOX17 and TFAP2C, drive the human germ-cell specification program."}, {"pubmed": 34036684, "text": "Fucosyltransferase 8 regulation and breast cancer suppression by transcription factor activator protein 2gamma."}, {"pubmed": 36197225, "text": "Roles of activator protein-2 gamma in breast cancer: A narrative review (SANRA)."}, {"pubmed": 36476988, "text": "HN1L/AP-2gamma/PLK1 signaling drives tumor progression and chemotherapy resistance in esophageal squamous cell carcinoma."}, {"pubmed": 36723462, "text": "Transcription factor AP-2 gamma/Kruppel-like factor 10 axis is involved in miR-3656-related dysfunction of endothelial cells in hypertension."}, {"pubmed": 36752341, "text": "KLF14/miR-1283/TFAP2C axis inhibits HER2-positive breast cancer progression via declining tumor cell proliferation."}, {"pubmed": 37169570, "text": "TFAP2C exacerbates psoriasis-like inflammation by promoting Th17 and Th1 cells activation through regulating TEAD4 transcription."}, {"pubmed": 37191968, "text": "TFAP2C inhibits cell autophagy to alleviate myocardial ischemia/reperfusion injury by regulating miR-23a-5p/SFRP5/Wnt5a axis."}, {"pubmed": 38243114, "text": "Lineage regulators TFAP2C and NR5A2 function as bipotency activators in totipotent embryos."}, {"pubmed": 38717933, "text": "CYP19A1 Expression Is Controlled by mRNA Stability of the Upstream Transcription Factor AP-2gamma in Placental JEG3 Cells."}, {"pubmed": 38789684, "text": "Tead4 and Tfap2c generate bipotency and a bistable switch in totipotent embryos to promote robust lineage diversification."}], "genomic_pos": {"chr": "20", "end": 56639283, "ensemblgene": "ENSG00000087510", "start": 56629306, "strand": 1}, "genomic_pos_hg19": {"chr": "20", "end": 55214339, "start": 55204358, "strand": 1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0000122", "qualifier": "involved_in", "term": "negative regulation of transcription by RNA polymerase II"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0006357", "qualifier": "involved_in", "term": "regulation of transcription by RNA polymerase II"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0007267", "pubmed": 9113991, "qualifier": "involved_in", "term": "cell-cell signaling"}, {"evidence": "IEP", "gocategory": "BP", "id": "GO:0008584", "pubmed": 17848411, "qualifier": "involved_in", "term": "male gonad development"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0042127", "qualifier": "involved_in", "term": "regulation of cell population proliferation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0045814", "pubmed": 24413532, "qualifier": "involved_in", "term": "negative regulation of gene expression, epigenetic"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045944", "pubmed": 22735262, "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0048856", "qualifier": "involved_in", "term": "anatomical structure development"}], "CC": [{"evidence": "ISA", "gocategory": "CC", "id": "GO:0000785", "qualifier": "part_of", "term": "chromatin"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005634", "qualifier": "is_active_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005634", "pubmed": 24413532, "qualifier": "located_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005739", "qualifier": "located_in", "term": "mitochondrion"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0000977", "qualifier": "enables", "term": "RNA polymerase II transcription regulatory region sequence-specific DNA binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0000978", "pubmed": 24413532, "qualifier": "enables", "term": "RNA polymerase II cis-regulatory region sequence-specific DNA binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0000981", "qualifier": "enables", "term": "DNA-binding transcription factor activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "ISA", "id": "GO:0000981", "qualifier": "enables", "term": "DNA-binding transcription factor activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "IDA", "id": "GO:0001227", "pubmed": 11278550, "qualifier": "enables", "term": "DNA-binding transcription repressor activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "IDA", "id": "GO:0001228", "pubmed": 11278550, "qualifier": "enables", "term": "DNA-binding transcription activator activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "IDA", "id": "GO:0003677", "pubmed": 12072434, "qualifier": "enables", "term": "DNA binding"}, {"category": "MF", "evidence": "TAS", "id": "GO:0003700", "pubmed": 9113991, "qualifier": "enables", "term": "DNA-binding transcription factor activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [11694877, 12072434, 12586840, 19115315, 24413532, 24835590], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:1990837", "pubmed": 28473536, "qualifier": "enables", "term": "sequence-specific double-stranded DNA binding"}]}, "homologene": {"genes": [[7955, 494033], [8364, 496506], [9031, 419327], [9544, 705384], [9598, 747174], [9606, 7022], [9615, 485941], [9913, 511317], [10090, 21420], [10116, 362280]], "id": 2423}, "interpro": [{"desc": "Transcription factor AP-2", "id": "IPR004979", "short_desc": "TF_AP2"}, {"desc": "Transcription factor AP-2 gamma", "id": "IPR008123", "short_desc": "TF_AP2_gamma"}, {"desc": "Transcription factor AP-2, C-terminal", "id": "IPR013854", "short_desc": "TF_AP2_C"}], "ipi": ["IPI00023260", "IPI00791453", "IPI01011996"], "map_location": "20q13.31", "name": "transcription factor AP-2 gamma", "other_names": ["activating enhancer-binding protein 2 gamma", "estrogen receptor factor 1", "transcription factor AP-2 gamma", "transcription factor ERF-1"], "pantherdb": {"HGNC": "11744", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "106032", "ortholog_type": "LDO", "panther_family": "PTHR10812", "taxid": 10090, "uniprot_kb": "Q61312"}, {"RGD": "1303185", "ortholog_type": "LDO", "panther_family": "PTHR10812", "taxid": 10116, "uniprot_kb": "Q4V8P9"}, {"Ensembl": "ENSGALG00000007690", "ortholog_type": "LDO", "panther_family": "PTHR10812", "taxid": 9031, "uniprot_kb": "E1C5K7"}, {"ZFIN": "ZDB-GENE-041212-61", "ortholog_type": "LDO", "panther_family": "PTHR10812", "taxid": 7955, "uniprot_kb": "Q5PQZ4"}, {"WormBase": "WBGene00009203", "ortholog_type": "O", "panther_family": "PTHR10812", "taxid": 6239, "uniprot_kb": "Q19862"}, {"WormBase": "WBGene00009202", "ortholog_type": "O", "panther_family": "PTHR10812", "taxid": 6239, "uniprot_kb": "Q19863"}, {"WormBase": "WBGene00013383", "ortholog_type": "O", "panther_family": "PTHR10812", "taxid": 6239, "uniprot_kb": "G2HK15"}, {"WormBase": "WBGene00019424", "ortholog_type": "LDO", "panther_family": "PTHR10812", "taxid": 6239, "uniprot_kb": "Q09585"}, {"FlyBase": "FBgn0261953", "ortholog_type": "LDO", "panther_family": "PTHR10812", "taxid": 7227, "uniprot_kb": "M9PIH9"}], "uniprot_kb": "Q92754"}, "pathway": {"pid": {"id": "tap63pathway", "name": "Validated transcriptional targets of TAp63 isoforms"}, "reactome": [{"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-1474165", "name": "Reproduction"}, {"id": "R-HSA-212436", "name": "Generic Transcription Pathway"}, {"id": "R-HSA-212436", "name": "Generic Transcription Pathway"}, {"id": "R-HSA-2990846", "name": "SUMOylation"}, {"id": "R-HSA-3108232", "name": "SUMO E3 ligases SUMOylate target proteins"}, {"id": "R-HSA-3232118", "name": "SUMOylation of transcription factors"}, {"id": "R-HSA-392499", "name": "Metabolism of proteins"}, {"id": "R-HSA-597592", "name": "Post-translational protein modification"}, {"id": "R-HSA-73857", "name": "RNA Polymerase II Transcription"}, {"id": "R-HSA-73857", "name": "RNA Polymerase II Transcription"}, {"id": "R-HSA-74160", "name": "Gene expression (Transcription)"}, {"id": "R-HSA-74160", "name": "Gene expression (Transcription)"}, {"id": "R-HSA-8864260", "name": "Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors"}, {"id": "R-HSA-8864260", "name": "Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors"}, {"id": "R-HSA-8866904", "name": "Negative regulation of activity of TFAP2 (AP-2) family transcription factors"}, {"id": "R-HSA-8866904", "name": "Negative regulation of activity of TFAP2 (AP-2) family transcription factors"}, {"id": "R-HSA-8866906", "name": "TFAP2 (AP-2) family regulates transcription of other transcription factors"}, {"id": "R-HSA-8866907", "name": "Activation of the TFAP2 (AP-2) family of transcription factors"}, {"id": "R-HSA-8866910", "name": "TFAP2 (AP-2) family regulates transcription of growth factors and their receptors"}, {"id": "R-HSA-8866911", "name": "TFAP2 (AP-2) family regulates transcription of cell cycle factors"}, {"id": "R-HSA-9758941", "name": "Gastrulation"}, {"id": "R-HSA-9758941", "name": "Gastrulation"}, {"id": "R-HSA-9827857", "name": "Specification of primordial germ cells"}, {"id": "R-HSA-9834899", "name": "Specification of the neural plate border"}, {"id": "R-HSA-9834899", "name": "Specification of the neural plate border"}], "wikipathways": [{"id": "WP2858", "name": "Ectoderm Differentiation"}, {"id": "WP4352", "name": "Ciliary landscape"}]}, "pfam": "PF03299", "pharmgkb": "PA36461", "pharos": {"target_id": 13177, "tdl": "Tbio"}, "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF257139", "relationship": "is"}, {"id": "GNF257140", "relationship": "is"}, {"id": "GNF257141", "relationship": "is"}, {"id": "GNF257142", "relationship": "is"}, {"id": "GNF272844", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF036926", "relationship": "similar to"}, "GNF_mm+hs-MGC": [{"id": "GNF014467", "relationship": "is"}, {"id": "GNF014468", "relationship": "is"}], "GNF_mm+hs_RetroCDNA": {"id": "GNF239051", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF106708", "relationship": "is"}, {"id": "GNF146354", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000020.11", "NC_060944.1"], "protein": "NP_003213.1", "rna": "NM_003222.4", "translation": {"protein": "NP_003213.1", "rna": "NM_003222.4"}}, "reporter": {"HG-U133_Plus_2": ["205286_at", "205287_s_at"], "HG-U95Av2": "40303_at", "HTA-2_0": "TC20000436.hg.1", "HuEx-1_0": "3890333", "HuGene-1_1": "8063536", "HuGene-2_1": "16915091"}, "summary": "The protein encoded by this gene is a sequence-specific DNA-binding transcription factor involved in the activation of several developmental genes. The encoded protein can act as either a homodimer or heterodimer with other family members and is induced during retinoic acid-mediated differentiation. It plays a role in the development of the eyes, face, body wall, limbs, and neural tube. [provided by RefSeq, Jul 2008].", "symbol": "TFAP2C", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1336606"}, "unigene": "Hs.473152", "uniprot": {"Swiss-Prot": "Q92754", "TrEMBL": "A2A2R7"}, "wikipedia": {"url_stub": "TFAP2C"}}